Pharmacokinetic and pharmacodynamic interactions between recombinant human luteinizing hormone and recombinant human follicle-stimulating hormone
- 28 February 1998
- journal article
- Published by Elsevier in Fertility and Sterility
- Vol. 69 (2) , 201-209
- https://doi.org/10.1016/s0015-0282(97)00503-7
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Clinical pharmacology of recombinant human luteinizing hormone: Part I. Pharmacokinetics after intravenous administration to healthy female volunteers and comparison with urinary human luteinizing hormoneFertility and Sterility, 1998
- Clinical pharmacology of recombinant human luteinizing hormone: Part II. Bioavailability of recombinant human luteinizing hormone assessed with an immunoassay and an in vitro bioassayFertility and Sterility, 1998
- Comprehensive Pharmacokinetics of Urinary Human Follicle Stimulating Hormone in Healthy Female VolunteersPharmaceutical Research, 1995
- Immunoreactive Inhibinα-Subunit in Human Serum: Implications for Radioimmunoassay*Journal of Clinical Endocrinology & Metabolism, 1990
- Stimulation of Ovarian Follicular Maturation With Pure Follicle-Stimulating Hormone in Women with Gonadotropin DeficiencyJournal of Clinical Endocrinology & Metabolism, 1988
- Understanding the Dose-Effect RelationshipClinical Pharmacokinetics, 1981
- EFFECTS OF HUMAN MENOPAUSAL GONADOTROPHIN PREPARATIONS IN DIFFERENT BIOASSAY METHODSActa Endocrinologica, 1964
- ASSAY OF THE FOLLICLE STIMULATING HORMONE BASED ON THE AUGMENTATION WITH HUMAN CHORIONIC GONADOTROPINEndocrinology, 1953